Michael Keating, MD, Oral History Interview, May 13, 2014
Loading...
Description
Major topics covered:
- Personal and educational background
- Faith, values, and the practice of medicine
- Research: combination therapies, Fludarabine, Cytarabine
- Impact of research on patients; patient commitment to treatment
- Setting up leukemia databases at MD Anderson
Identifier
KeatingM_01_20140313
Publication Date
3-13-2014
Publisher
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Keating, Michael MD and Rosolowski, Tacey A. PhD, "Michael Keating, MD, Oral History Interview, May 13, 2014" (2014). Interview Sessions. 237.
https://openworks.mdanderson.org/mchv_interviewsessions/237
Conditions Governing Access
Redacted
About the Interview
About the Interview Subject:
Michael Keating, M.D. (b. 1 July 1943, Melbourne, Australia) came to MD Anderson as a Fellow in the Department of Developmental Therapeutics in 1974 and joined the faculty as an Assistant Professor in 1978. Today he is a professor of medicine in the Department of Leukemia in the Division of Cancer Medicine. Dr. Keating established his reputation with his investigations into the natural histories of chronic lymphocytic leukemia and his collaborative work on drug treatments, combination treatments, and multi-modality treatments for leukemia, a number of which became standard of care. Dr. Keating served as Associate Vice President for Patient Care in Clinical Investigations from 1990 – 1995. From 1995 to 1999 he served as Associate Head for Clinical Research in Leukemia. He is currently co-leader of the Chronic Lymphocytic Leukemia Moon Shot Program. Dr. Keating is also the Founding President and CEO of the Global Research Foundation, a non-profit organization supporting research into Chronic Lymphocytic Leukemia. The interview sessions take place in a conference room in the Department of Leukemia in the Faculty Center on the Main Campus of MD Anderson. Tacey A. Rosolowski, Ph.D. is the interviewer.